Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I.

A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I. Mol Genet Metab. 2009 Jan; 96(1):13-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.